Cortisol response to a psychosocial stressor in schizophrenia: Blunted, delayed, or normal?

Psychoneuroendocrinology

Volumn 34, Issue 6, 2009, Pages 859-868

  Brenner, K ^a,b   Liu, A ^c   Laplante, D P ^b   Lupien, S ^b,c   Pruessner, J C ^b,c   Ciampi, A ^c   Joober, R ^b,c   King, S ^b,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^c NONE   (Canada)

Author keywords

Psychosocial stress; Salivary cortisol; Schizophrenia; TSST

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; BODY MASS; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MENTAL STRESS; PERSONALITY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SALIVA LEVEL; SCHIZOPHRENIA; SMOKING HABIT; SOCIAL STRESS; STEROID RELEASE; TRIER SOCIAL STRESS TEST;

ADAPTATION, PHYSIOLOGICAL; ADULT; BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; SALIVA; SCHIZOPHRENIA; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL; TIME FACTORS; YOUNG ADULT;

EID: 67349202764     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.01.002     Document Type: Article

References (43)

1. Albus M., Ackenheil M., Engel R.R., and Muller F. Situational reactivity of autonomic functions in schizophrenic patients. Psychiatry Res. 6 (1982) 361-370
2. Bauer M.E. Stress, glucocorticoids and ageing of the immune system. Stress 8 (2005) 69-83
3. Biondi M., and Picardi A. Psychological stress and neuroendocrine function in humans: the last two decades of research. Psychother. Psychosom. 68 (1999) 114-150
4. Breier A., Wolkowitz O.M., Doran A.R., Bellar S., and Pickar D. Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers. Psychiatry Res. 25 (1988) 187-194
5. Brenner K., Schmitz N., Pawliuk N., Fathalli F., Joober R., Ciampi A., and King S. Validation of the CAPE with a Montreal Community Sample. Schizophrenia Res. 95 (2007) 86-95
6. Cacioppo J.T., Tassinary L.G., and Berntson G.G. Handbook of Psychophysiology. 3rd ed. (2007), Cambridge University Press, Cambridge (England)/New York
7. Chiodera P., Volpi R., Capretti L., Speroni G., Necchi-Ghiri S., Caffarri G., Colla R., and Coiro V. Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. Clin. Endocrinol. (Oxf) 46 (1997) 351-357
8. Corcoran C., Gallitano A., Leitman D., and Malaspina D. The neurobiology of the stress cascade and its potential relevance for schizophrenia. J. Psychiatr. Prac. 7 (2001) 3-14
9. Costa J.F., and McCrae R.R. Revised NEO Personality Inventory (NEO-PI) and NEO Five-Factor Inventory (NEO-FFI) Professional Manual (1992), Psychological Assessment Resources, Odessa, FL
10. Dickerson S.S., and Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol. Bull. 130 (2004) 355-391
11. Dressendorfer R.A., Kirschbaum C., Rohde W., Stahl F., and Strasburger C.J. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J. Steroid Biochem. Mol. Biol. 43 (1992) 683-692
12. Frederick S.L., Reus V.I., Ginsberg D., Hall S.M., Munoz R.F., and Ellman G. Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers. Biol. Psychiatry 43 (1998) 525-530
13. Gispen-de Wied C.C. Stress in schizophrenia: an integrative view. Eur. J. Pharmacol. 405 (2000) 375-384
14. Hellerstein D.J., Almeida G., Devlin M.J., Mendelsohn N., Helfand S., Dragatsi D., Miranda R., Kelso J.R., and Capitelli L. Assessing obesity and other related health problems of mentally ill Hispanic patients in an urban outpatient setting. Psychiatr. Q. 78 (2007) 171-181
15. Jansen L.M., Gispen-de Wied C.C., and Kahn R.S. Selective impairments in the stress response in schizophrenic patients. Psychopharmacology (Berl) 149 (2000) 319-325
16. Jansen L.M.C., Gispen-de Wied C.C., Gademan P.J., De Jonge R.C.J., van der Linden J.A., and Kahn R.S. Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophrenia Res. 33 (1998) 87-94
17. Kaneda Y., Fujii A., and Ohmori T. The hypothalamic-pituitary-adrenal axis in chronic schizophrenic patients long-term treated with neuroleptics. Prog. Neuropsychopharmacol. Biol. Psychiatry 26 (2002) 935-938
18. Kirschbaum C., and Hellhammer D.H. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 19 (1994) 313-333
19. Kirschbaum C., Pirke K.M., and Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28 (1993) 76-81
20. Kirschbaum C., Wust S., and Hellhammer D. Consistent sex differences in cortisol responses to psychological stress. Psychosom. Med. 54 (1992) 648-657
21. Kudoh A., Ishihara H., and Matsuki A. Pituitary-adrenal and parasympathetic function in chronic schizophrenic patients with postoperative ileus or hypotension. Neuropsychobiology 39 (1999) 125-130
22. Kudoh A., Kudo K., and Ishihara A. Depressed pituitary-adrenal response to surgical stress in chronic schizophrenic patients. Neuropsychobiology 36 (1997) 112-116
23. Levenson R.W., Sher K.J., Grossman L.M., Newman J., and Newlin D.B. Alcohol and stress response dampening: pharmacological effects, expectancy, and tension reduction. J. Abnorm. Psychol. 89 (1980) 528-538
24. Lukoff, D., Nuecheterlein, K.H., Ventura, J., 1986. Appendix A: manual for the expanded BPRS. In: Lukoff, D., Liberman, R.P., Nuechterlein, K.H. (Eds.). Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bull. 12, 594-602.
25. Marcelis M., Cavalier E., Gielen J., Delespaul P., and Van Os J. Abnormal response to metabolic stress in schizophrenia: marker of vulnerability or acquired sensitization?. Psychol. Med. 34 (2004) 1103-1111
26. Meador-Woodruff J.H., and Greden J.F. Effects of psychotropic medications on hypothalamic-pituitary-adrenal regulation. Neurol. Clin. 6 (1988) 225-234
27. Meltzer H.Y. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berl) 99 Suppl. (1989) S18-S27
28. Meulenberg P.M., and Hofman J.A. The effect of oral contraceptive use and pregnancy on the daily rhythm of cortisol and cortisone. Clin. Chim. Acta 190 (1990) 211-221
29. Norman R.M., and Malla A.K. Stressful life events and schizophrenia. I: A review of the research. Br. J. Psychiatry 162 (1993) 161-166
30. Oswald L.M., Zandi P., Nestadt G., Potash J.B., Kalaydjian A.E., and Wand G.S. Relationship between cortisol responses to stress and personality. Neuropsychopharmacology 31 (2006) 1583-1591
31. Pickworth W.B., Baumann M.H., Fant R.V., Rothman R.B., and Henningfield J.E. Endocrine responses during acute nicotine withdrawal. Pharmacol. Biochem. Behav. 55 (1996) 433-437
32. Pruessner J.C., Kirschbaum C., Meinlschmid G., and Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28 (2003) 916-931
33. Puddey I.B., Vandongen R., Beilin L.J., and English D. Haemodynamic and neuroendocrine consequences of stopping smoking-a controlled study. Clin. Exp. Pharmacol. Physiol. 11 (1984) 423-426
34. Scheepers F.E., Gespen de Wied C.C., and Kahn R.S. The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia. J. Clin. Psychopharmacol. 21 (2001) 575-582
35. Smyth J.M., Ockenfels M.C., Gorin A.A., Catley D., Porter L.S., Kirschbaum C., Hellhammer D.H., and Stone A.A. Individual differences in the diurnal cycle of cortisol. Psychoneuroendocrinology 22 (1997) 65-128
36. Steele C.M., and Josephs R.A. Drinking your troubles away. II: An attention-allocation model of alcohol's effect on psychological stress. J. Abnorm. Psychol. 97 (1988) 196-205
37. Stefanis N.C., Hanssen M., Smirnis N.K., Avramopoulos D.A., Evdokimidis I.K., Stefanis C.N., Verdoux H., and Van Os J. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol. Med. 32 (2002) 347-358
38. Sussman N. Review of atypical antipsychotics and weight gain. J. Clin. Psychiatry 62 Suppl. 23 (2001) 5-12
39. Tabachnick B.G., and Fidell L.S. Using Multivariate Statistics. 2 ed. (1989), Harper & Row, Publishers, Inc., New York, NY
40. Ventura J., Nuechterlein K.H., Subotnik K., and Gilbert E. Symptom dimensions in recent-onset schizophrenia: the 24-item expanded BPRS. International Congress on Schizophrenia Research. Hot Springs, Virginia (1995)
41. Walder D.J., Walker E.F., and Lewine R.J. Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia. Biol. Psychiatry 48 (2000) 1121-1132
42. Walker E.F., and Diforio D. Schizophrenia: a neural diathesis-stress model. Psychol. Rev. 104 (1997) 667-685
43. Wik G. Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood. J. Endocrinol. 144 (1995) 425-429